S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in

Yield10 Bioscience Stock Forecast, Price & News

+0.60 (+4.31 %)
(As of 03/3/2021 12:00 AM ET)
Today's Range
Now: $14.53
50-Day Range
MA: $15.80
52-Week Range
Now: $14.53
Volume120,167 shs
Average Volume373,810 shs
Market Capitalization$66.91 million
P/E RatioN/A
Dividend YieldN/A
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Yield10 Bioscience logo


Yield10 Bio secures $12.7M capital raise
February 3, 2021 |  seekingalpha.com
Yield10 Bioscience, Inc.
December 3, 2020 |  fool.com
Yield10 Bioscience EPS beats by $0.07, misses on revenue
November 12, 2020 |  seekingalpha.com
Yield10 Bioscience Inc.
November 4, 2020 |  barrons.com
Yield10 Bioscience, Inc. Common Stock (YTEN)
October 28, 2020 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry Miscellaneous plastics products
Current SymbolNASDAQ:YTEN
Year FoundedN/A



Sales & Book Value

Annual Sales$810,000.00
Book Value($4.38) per share


Net Income$-12,960,000.00
Net Margins-1,861.39%


Market Cap$66.91 million
Next Earnings Date3/18/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.62 out of 5 stars

Consumer Staples Sector

70th out of 301 stocks

Miscellaneous Plastics Products Industry

1st out of 4 stocks

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
+0.60 (+4.31 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

Is Yield10 Bioscience a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Yield10 Bioscience stock.
View analyst ratings for Yield10 Bioscience
or view top-rated stocks.

What stocks does MarketBeat like better than Yield10 Bioscience?

Wall Street analysts have given Yield10 Bioscience a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Yield10 Bioscience wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Yield10 Bioscience?

Yield10 Bioscience saw a decline in short interest in the month of February. As of February 12th, there was short interest totaling 27,700 shares, a decline of 61.6% from the January 28th total of 72,100 shares. Based on an average daily trading volume, of 262,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.9% of the shares of the stock are sold short.
View Yield10 Bioscience's Short Interest

When is Yield10 Bioscience's next earnings date?

Yield10 Bioscience is scheduled to release its next quarterly earnings announcement on Thursday, March 18th 2021.
View our earnings forecast for Yield10 Bioscience

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced its quarterly earnings results on Tuesday, November, 17th. The specialty chemicals company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.81) by $0.06. The specialty chemicals company had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.23 million. Yield10 Bioscience had a negative net margin of 1,861.39% and a negative trailing twelve-month return on equity of 347.89%.
View Yield10 Bioscience's earnings history

How has Yield10 Bioscience's stock been impacted by COVID-19?

Yield10 Bioscience's stock was trading at $4.82 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, YTEN shares have increased by 201.5% and is now trading at $14.53.
View which stocks have been most impacted by COVID-19

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience's stock reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2020. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for YTEN?

3 brokerages have issued 12 month price objectives for Yield10 Bioscience's shares. Their forecasts range from $15.00 to $25.00. On average, they expect Yield10 Bioscience's share price to reach $21.33 in the next year. This suggests a possible upside of 46.8% from the stock's current price.
View analysts' price targets for Yield10 Bioscience
or view top-rated stocks among Wall Street analysts.

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the following people:
  • Dr. Oliver P. Peoples, Co-Founder, Pres, CEO & Director (Age 63, Pay $287.26k)
  • Dr. Anthony J. Sinskey Ph.D., Sc.D., Co-Founder & Independent Director (Age 81, Pay $47.5k)
  • Dr. Kristi D. Snell, VP of Research & Chief Science Officer (Age 53, Pay $243.76k)
  • Ms. Lynne H. Brum, VP of Planning & Corp. Communications and Sec. (Age 57, Pay $243.79k)
  • Mr. Charles B. Haaser, VP of Fin., Chief Accounting Officer & Treasurer (Age 65)

Who are some of Yield10 Bioscience's key competitors?

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), (CGC), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), (SCON) and Advanced Micro Devices (AMD).

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

Who are Yield10 Bioscience's major shareholders?

Yield10 Bioscience's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Cannell Peter B & Co. Inc. (3.14%) and Renaissance Technologies LLC (0.92%). Company insiders that own Yield10 Bioscience stock include Jack W Schuler and Oliver P Peoples.
View institutional ownership trends for Yield10 Bioscience

Which major investors are selling Yield10 Bioscience stock?

YTEN stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
View insider buying and selling activity for Yield10 Bioscience
or view top insider-selling stocks.

Which major investors are buying Yield10 Bioscience stock?

YTEN stock was purchased by a variety of institutional investors in the last quarter, including Cannell Peter B & Co. Inc.. Company insiders that have bought Yield10 Bioscience stock in the last two years include Jack W Schuler, and Oliver P Peoples.
View insider buying and selling activity for Yield10 Bioscience
or or view top insider-buying stocks.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $14.53.

How much money does Yield10 Bioscience make?

Yield10 Bioscience has a market capitalization of $66.91 million and generates $810,000.00 in revenue each year. The specialty chemicals company earns $-12,960,000.00 in net income (profit) each year or ($35.50) on an earnings per share basis.

How many employees does Yield10 Bioscience have?

Yield10 Bioscience employs 25 workers across the globe.

What is Yield10 Bioscience's official website?

The official website for Yield10 Bioscience is www.yield10bio.com.

Where are Yield10 Bioscience's headquarters?

Yield10 Bioscience is headquartered at 19 PRESIDENTIAL WAY, WOBURN MA, 01801.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]

This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.